Skip to content

A Case Management Algorithm for Women Victims of Violence

Effectiveness of a Case Management Algorithm on Clinical Outcome After Consultations Requested in a Clinical Forensic Medicine Unit by Female Victims of Violence

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04953273
Acronym
VIGITRAUMA
Enrollment
756
Registered
2021-07-07
Start date
2021-07-06
Completion date
2026-07-01
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder, Violence-Related Symptom

Keywords

Post-Traumatic Stress Disorder, Women Health, Physical Abuse, Forensic Medicine, Case-Management Algorithm

Brief summary

A considerable body of research has demonstrated that women who are victims of interpersonal violence are at substantially elevated risk for the development of post-traumatic stress disorder (PTSD). In France, victims can request a medico-legal examination in a clinical forensic medicine unit. Although these units are also a place for initial psychological examination, women often don't attend future scheduled appointments. Decision-making algorithm using phone contact are effective in suicide prevention. Our aim is to assess the effectiveness of case management algorithm using early phone contact compared to a control group treated as usual on clinical outcome after consultation requested in a clinical forensic medicine unit by female victims of violence. Method: Prospective, multicenter, open-label, randomized controlled clinical trial, for women victims of violence. Victims randomized in VIGITRAUMA group will be contacted by phone at 3 weeks after the consultation in a clinical forensic medicine unit, and a second phone call can be done. If the subject is not contacted after the second phone call, he will receive a postcard. Control group will benefit from usual follow-up. All the subjects included will be then evaluated at 3 months, 6 months and 1 year during a phone call.

Interventions

OTHERVigitrauma

Case management algorithm using early phone contact

Sponsors

University Hospital, Lille
Lead SponsorOTHER
Ministry of Health, France
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women * 18 years and older * Consultation requested in a clinical forensic medicine unit after being victim of violence * The person was exposed to: death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence (PTSD criterion A - DSM -5) * With social insurance * Consent to participate to the study

Exclusion criteria

* Do no consent to participate to the study * Intrafamilial or intimate partner violence * Do not speak french

Design outcomes

Primary

MeasureTime frameDescription
Clinical Outcome3 monthsRate of patients with a Clinical Global Impression (CGI) severity scale \< 4

Secondary

MeasureTime frameDescription
Severity of post-traumatic stress disorder symptoms3 months, 6 months and 12 monthsPost-traumatic stress disorder Checklist Scale-5
General psychopathology3 months, 6 months and 12 monthsFrench version of Mini International Neuropsychiatric Interview (DSM 5)
Severity of somatic symptoms3 months, 6 months and 12 monthsPhysical Health Questionnaire (PHQ-15)
Medical cost12 monthsNnumber of hospitalizations, consultations, and drugs consummation
Judicial outcome12 monthsNumber of days of temporary inability to work
Suicidal ideation intensity12 monthsThe Beck Scale for Suicide Ideation (SSI) The Scale for Suicide Ideation (SSI; Beck, et al., 1979) is a brief 21-item scale that assesses the person's current intensity of attitudes, plans, and behaviors to commit suicide.
Number of suicide attempters12 monthsSuicide risk

Countries

France

Contacts

CONTACTArnaud Leroy, MD
arnaud.leroy@chru-lille.fr+33 320444460
CONTACTAnne-Laure Demarty
anne-laure.demarty@chru-lille.fr+33 320444145
PRINCIPAL_INVESTIGATORArnaud Leroy, MD

University Hospital, Lille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026